147 related articles for article (PubMed ID: 14651635)
1. Heterologous expression of a mammalian protein tyrosine phosphatase gene in Leishmania: effect on differentiation.
Nascimento M; Abourjeily N; Ghosh A; Zhang WW; Matlashewski G
Mol Microbiol; 2003 Dec; 50(5):1517-26. PubMed ID: 14651635
[TBL] [Abstract][Full Text] [Related]
2. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2.
Zhang WW; Matlashewski G
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8807-11. PubMed ID: 9238059
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a protein-tyrosine phosphatase in Leishmania: Involvement in virulence.
Nascimento M; Zhang WW; Ghosh A; Houston DR; Berghuis AM; Olivier M; Matlashewski G
J Biol Chem; 2006 Nov; 281(47):36257-68. PubMed ID: 17005559
[TBL] [Abstract][Full Text] [Related]
4. Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.
Saar Y; Ransford A; Waldman E; Mazareb S; Amin-Spector S; Plumblee J; Turco SJ; Zilberstein D
Mol Biochem Parasitol; 1998 Sep; 95(1):9-20. PubMed ID: 9763285
[TBL] [Abstract][Full Text] [Related]
5. Involvement of protein tyrosine kinases and phosphatases in uptake and intracellular replication of virulent and avirulent Leishmania donovani promastigotes in mouse macrophage cells.
Ghosh D; Chakraborty P
Biosci Rep; 2002; 22(3-4):395-406. PubMed ID: 12516781
[TBL] [Abstract][Full Text] [Related]
6. Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene.
Charest H; Matlashewski G
Mol Cell Biol; 1994 May; 14(5):2975-84. PubMed ID: 7545921
[TBL] [Abstract][Full Text] [Related]
7. Transgenic analysis of the Leishmania MAP kinase MPK10 reveals an auto-inhibitory mechanism crucial for stage-regulated activity and parasite viability.
Cayla M; Rachidi N; Leclercq O; Schmidt-Arras D; Rosenqvist H; Wiese M; Späth GF
PLoS Pathog; 2014 Sep; 10(9):e1004347. PubMed ID: 25232945
[TBL] [Abstract][Full Text] [Related]
8. Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts.
Gaur U; Showalter M; Hickerson S; Dalvi R; Turco SJ; Wilson ME; Beverley SM
Exp Parasitol; 2009 Jul; 122(3):182-91. PubMed ID: 19328787
[TBL] [Abstract][Full Text] [Related]
9. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation.
Blanchette J; Racette N; Faure R; Siminovitch KA; Olivier M
Eur J Immunol; 1999 Nov; 29(11):3737-44. PubMed ID: 10556830
[TBL] [Abstract][Full Text] [Related]
10. The Leishmania donovani histidine acid ecto-phosphatase LdMAcP: insight into its structure and function.
Papadaki A; Politou AS; Smirlis D; Kotini MP; Kourou K; Papamarcaki T; Boleti H
Biochem J; 2015 May; 467(3):473-86. PubMed ID: 25695743
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection.
Zhang WW; Matlashewski G
Mol Microbiol; 2001 Feb; 39(4):935-48. PubMed ID: 11251814
[TBL] [Abstract][Full Text] [Related]
12. Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani.
Zhang WW; Charest H; Ghedin E; Matlashewski G
Mol Biochem Parasitol; 1996 Jun; 78(1-2):79-90. PubMed ID: 8813679
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A signaling during bidirectional axenic differentiation in Leishmania.
Bachmaier S; Witztum R; Tsigankov P; Koren R; Boshart M; Zilberstein D
Int J Parasitol; 2016 Feb; 46(2):75-82. PubMed ID: 26460237
[TBL] [Abstract][Full Text] [Related]
14. The
Papadaki A; Tziouvara O; Kotopouli A; Koumarianou P; Doukas A; Rios P; Tardieux I; Köhn M; Boleti H
Front Cell Infect Microbiol; 2021; 11():591868. PubMed ID: 33842381
[TBL] [Abstract][Full Text] [Related]
15. Involvement of a Leishmania thymidine kinase in flagellum formation, promastigote shape and growth as well as virulence.
Thiel M; Harder S; Wiese M; Kroemer M; Bruchhaus I
Mol Biochem Parasitol; 2008 Apr; 158(2):152-62. PubMed ID: 18222009
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.
Rachidi N; Taly JF; Durieu E; Leclercq O; Aulner N; Prina E; Pescher P; Notredame C; Meijer L; Späth GF
Antimicrob Agents Chemother; 2014; 58(3):1501-15. PubMed ID: 24366737
[TBL] [Abstract][Full Text] [Related]
17. A unique, highly conserved secretory invertase is differentially expressed by promastigote developmental forms of all species of the human pathogen, Leishmania.
Lyda TA; Joshi MB; Andersen JF; Kelada AY; Owings JP; Bates PA; Dwyer DM
Mol Cell Biochem; 2015 Jun; 404(1-2):53-77. PubMed ID: 25763714
[TBL] [Abstract][Full Text] [Related]
18. Stage-specific expression of the proline-alanine transporter in the human pathogen Leishmania.
Liburkin-Dan T; Schlisselberg D; Fischer-Weinberger R; Pescher P; Inbar E; Ephros M; Rentsch D; Späth GF; Zilberstein D
Mol Biochem Parasitol; 2018 Jun; 222():1-5. PubMed ID: 29655799
[TBL] [Abstract][Full Text] [Related]
19. Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1.
Nandan D; Reiner NE
Clin Immunol; 2005 Mar; 114(3):266-77. PubMed ID: 15721837
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning, biochemical and structural analysis of elongation factor-1 alpha from Leishmania donovani: comparison with the mammalian homologue.
Nandan D; Cherkasov A; Sabouti R; Yi T; Reiner NE
Biochem Biophys Res Commun; 2003 Mar; 302(4):646-52. PubMed ID: 12646217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
